September 26-28, 2016 | Omni Shoreham Hotel | Washington, D.C.
There is still time to register for the 2016 NASP Annual Meeting & Expo, the comprehensive national meeting for all stakeholders in the industry. Join industry leaders of specialty pharmacy as they gather for the 2016 NASP Annual Meeting, September 26-28, at the Omni Shoreham Hotel in Washington, DC.
In addition, NASP’s first Specialty Pharmacy Law Conference, will be held on September 26 at the same location. This is a unique, one-day conference for attorneys and others concerned with legal and regulatory aspects of managing and operating a specialty pharmacy. Sessions will offer CLE credit.
The NASP’s Specialty Pharmacy Law Conference is intended for general counsel and in-house counsel for national and regional specialty pharmacies, practicing attorneys in health care law, compliance officers or executives in specialty pharmacies or other settings concerned with the legal and regulatory aspects of operating a specialty pharmacy.
The program for the 2016 NASP Annual Meeting begins on September 27. This year’s NASP meeting has an expanded education program with more than 30 sessions including a look at specialty pharmacy from the patient’s perspective, biosimilars, 340B, best practices in specialty pharmacy, value-based reimbursement, employer perspectives on specialty pharmacy, the coming impact of developments in genomics, specialty pharmacy in health systems, a perspective on how the upcoming presidential election will affect specialty pharmacy, and clinical sessions on immuno-oncology, multiple sclerosis, and NASH.
Registration is open and the fee for the Specialty Pharmacy Law Conference may be applied toward registration for the 2016 NASP Annual Meeting & Expo, which is that same week at the same location.
Register today for these singular specialty pharmacy events that can offer significant insights and have influential and positive impacts on your business.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment